Myotec Therapeutics Overview
- Founded
-
2006
- Status
-
Acquired/Merged
- Latest Deal Type
-
Merger of Eq.
Myotec Therapeutics General Information
Description
Developer of novel therapeutics for the treatment of cancer and other clinically unmet diseases. The company develops drugs for the treatment of cancer.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 154B Milton Park
- Abingdon OX14 4SD
- England, United Kingdom
Myotec Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger of Equals | 15-Dec-2010 | 00.000 | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 08-Mar-2010 | 00.000 | 00.000 | 000.00 | Completed | Startup |
| 1. Seed Round | Completed | Startup |
Myotec Therapeutics Patents
Myotec Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0904261-D0 | New therapeutic use | Inactive | 12-Mar-2009 | ||
| GB-0809028-D0 | New threapeutic use | Inactive | 19-May-2008 | ||
| GB-0804454-D0 | New therapeutic use | Inactive | 11-Mar-2008 |
Myotec Therapeutics Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stefan Anker Ph.D | Scientific Founder |
Myotec Therapeutics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Invesco Perpetual | Asset Manager | Minority | 000 0000 | 000000 0 | |
| Touchstone Innovations | Venture Capital | Minority | 000 0000 | 000000 0 |
Myotec Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000 | 01-Jan-2010 | 000000 00 | Drug Discovery |